Original filing (PDF)20250420170849NAL0002095569001

SUMMIT APPLIED RESEARCH, INC.

Name: SUMMIT APPLIED RESEARCH, INC. — MONEY PURCHASE, Form 5500 (2024)
Creator: SUMMIT APPLIED RESEARCH, INC.

Form 5500-SF

FILING_RECEIVED

MONEY PURCHASE

Defined-contribution retirement plan

Signals · 1

High average account balance

Active participants

Accounts w/ balance

Plan assets (EOY)

$533K

Net assets (EOY)

$533K

Plan health score

Top-tier plan health

Directional indicator from public Form 5500 data — compliance & integrity, total plan cost, participant health and vendor stack, benchmarked against same-size peers. Not a fiduciary tool. Based on 70% of scoring inputs for this filing.

Compliance & integrity

100

Total plan cost

n/a

Plan health

Vendor & structure

100

Helping the score

Cost not scored — no comparable Schedule H expense data for this cohort.
High average account balance (95th percentile).

Decision-maker contacts

One unlock reveals every key decision-maker — plan signer, CFO, HR & Benefits — with verified email + LinkedIn for SUMMIT APPLIED RESEARCH, INC..

Plan sponsor

Name

SUMMIT APPLIED RESEARCH, INC.

EIN

22-3419137

Address

164 CANOE BROOK PKWY · SUMMIT, NJ · 079011632

Phone

—

Industry

Professional & Technical Servicessee all

Plan administrator

Same as plan sponsor.

Plan characteristics

Plan number

001

Plan year

2024

Plan year begin

2024-01-01

Tax period

2024-12-31

Filed

2025-04-20

Pension benefit codes

2B · Target benefit

2C · Money purchase (other than target benefit)

Audit & trust (Schedule H)

Auditor

—

Trustee / custodian

—

Trustee phone

—

Small plan (5500-SF) — Schedule H data not available.

Service providers (Schedule C)

Small plans don't disclose service providers

Related plans

Similar-size Professional & Technical Services plans

BIOTRIAL, INC.

BIOTRIAL, INC. 401(K) PLAN

$533K · 24 participants

ACCEL CLINICAL SOLUTIONS, LLC

ACCEL CLINICAL SOLUTIONS, LLC 401(K) PLAN

$532K · 2 participants

BIOINVENU CORPORATION

BIOINVENU CORPORATION 401(K) PROFIT SHARING PLAN

$533K · 1 participants

SHANTON PHARMA USA INC

SHANTON PHARMA USA INC 401K

$531K · 7 participants

CHILDRENS RESEARCH TRIANGLE

CHILDREN'S RESEARCH TRIANGLE 401(K) PLAN

$531K · 45 participants